England Could Eliminate HIV Transmission by 2030
England is on track to have diagnosed 95% of people living with HIV by 2025, putting it in a position to eliminate HIV transmission by 2030.
Category: Sexually Transmitted Diseases
Sexually Transmitted Diseases
Latest
Sexually Transmitted Diseases
Latest
Binx Health Inks Distribution Agreement for binx io Launch
The binx io provides results in about 30 minutes, which enables diagnosis and treatment of chlamydia and gonorrhea in a single visit.
Sexually Transmitted Diseases
Latest
USPSTF Final Recommendation on Screening for Bacterial Vaginosis to Prevent Preterm Delivery
The task force recommends against screening pregnant people for bacterial vaginosis if they are not at increased risk for preterm delivery.
Molecular Assays Focus on Diagnostic Testing for Vaginitis
Improved accuracy in detecting bacterial vaginosis, Candida vaginitis, and Trichomonas vaginalis will enable more targeted treatment for women.
Read More
Quest Diagnostics Launches Test Panel to Guide HIV Therapy
The testing service aims to facilitate guideline-based care to improve quality and convenience.
Read More
FDA Clears First Diagnostics for Extragenital Chlamydia and Gonorrhea
The Aptima Combo 2 and Xpert CT/NG are the first assays cleared to perform extragenital diagnostic testing for chlamydia and gonorrhea via specimens from the throat and rectum.
Read More
FDA Clears Single-Slide Combination STI Test
Addition of the Cobas TV/MG test offers the flexibility needed to process tests for up to four sexually transmitted infections from a single patient sample.
Read More
Quest Diagnostics Launches First Direct-to-Consumer STD Testing Service
Available nationwide, the new service links consumer-initiated testing with medical oversight and counseling to help combat the nation’s record rate of STDs.
Read More
New Test Enables Resistance-Guided Therapy for Gonorrhea
The ResistancePlus GC molecular diagnostic simultaneously diagnoses N. gonorrhoeae and provides antimicrobial susceptibility information, overcoming many of the issues associated with culture-based methods.
Read MoreFDA Clears HSV 1 and 2 Assay from ELITechGroup
The molecular test detects and differentiates the nucleic acid of herpes simplex viruses 1 and 2 isolated from swab specimens from cutaneous or mucocutaneous lesions on symptomatic patients.
Read More
Routine Nucleic Acid Amplification Testing for Trichomoniasis
Advanced testing methods promise improved patient outcomes and better protection of public health—with potential cost savings.
Read More
The Case for Universal STI Screening
A broader screening approach may improve population-level control of sexually transmitted infections.
Read More
The Evolution of Syphilis Testing
With syphilis rates on the rise, a reverse screening algorithm offers high clinical value.
Read More
FDA Lists SpeeDx Control Kit for Antibiotic-Resistant STI
The kit contains synthetic DNA to simulate Mycoplasma genitalium, as well as five mutations known to confer resistance to macrolide antibiotics.
Read More
Inside Track: Overcoming Obstacles to STI Testing
To find out more about Quest’s new survey on sexually transmitted infections, CLP recently spoke with Damian P. Alagia III, MD, FACOG, FACS, medical director for women’s health at Quest Diagnostics.
Read More
Siemens Healthineers Acquires Fast Track Diagnostics
The acquisition of FTD increases the menu of the Siemens Healthineers Versant kinetic polymerase chain reaction molecular system by more than 80 assays and syndromic panels.
Read More
SpeeDx Establishes US Subsidiary
The company will use its US base to support current clinical trial activity for ResistancePlus MG in preparation for an expected 2018 launch.
Read More
SpeeDx Obtains CE Mark for Sexually Transmitted Disease Detection
Validated for use on multiple lesion specimen types, the test is designed to streamline workflows and support rapid, appropriate clinical management of infections with similar symptoms.
Read More